ROLE OF COMMUNITY PARAMEDICINE IN NON-EMERGENCY PRESENTATIONS
Dr Robbie King
Lecturer in paramedicine and researcher, Australian Catholic University (ACU) Brisbane &
Senior Advanced Care Paramedic/Community Paramedic,
Sunshine Coast District, Birtinya Station,
Queensland Ambulance Service, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Queensland | November 2024
Dr Robbie King is a Lecturer in paramedicine and researcher at the Australian Catholic University (ACU) Brisbane. He also continues to provide clinical care as a registered paramedic for community members served by a jurisdictional ambulance service. Dr King has gained significant experience working in an advanced practice, community paramedic style role, holding expert clinical insight into the nuances of paramedic-led community-based healthcare for non-emergency presentations. This often involves adopting a biopsychosocial approach, rather than following the biomedical model more associated with emergency medicine and paramedic culture.
To encourage a patient-centred approach to paramedic-led healthcare by exploring the unmet needs of people requesting unscheduled emergency ambulance care, Dr King advocates for greater consumer engagement in paramedic research. He completed his PhD in early 2024 which explored the patient perspective of paramedic-led healthcare when patients were not transported to hospital. This research generated a theory that describes a process of patients ‘restoring self-efficacy’ when their vulnerabilities are validated, and they receive clinically competent and compassionate care.
Dr King has presented at professional symposium internationally, and in Australia where he continues to encourage greater consumer involvement in research to inform development of paramedic education and ambulance service models of healthcare delivery. Dr King is a Fellow of the Australasian College of Paramedicine and member of various professional research and Community Paramedic working groups. His research focus includes exploring the role of community paramedics in improving health literacy, self-efficacy, and addressing the psychosocial needs of patients requesting emergency ambulance services.
-
Infections and other lung diseases using models of human lung tissue grown from stem cells
Dr Rhiannon Werder is a Team Leader at Murdoch Children’s Research Institute leading a multidisciplinary team, combining expertise in stem cell biology and immunology, to develop new therapies for lung diseases. Her research centres around induced pluripotent stem cells to investigate respiratory diseases, spanning acute respiratory infections to chronic lung diseases. Using stem cells, Dr Werder’s team creates models of human lung tissue. With these models, Dr Werder is investigating how human-specific pathogens infect different regions of the lung, the ensuing immune responses, and how the lung repairs itself after infections, especially in people with preexisting lung diseases.
-
Touched by bowel cancer and chasing science outcomes
Dr Josephine Wright is a Senior Research Fellow in the Gut Cancer group. She has been developing a translational network of labs, hospitals and clinics to enable validation of new approaches to prevent and treat colorectal and gastric cancer. Her key focus is studying human tumour organoids to better personalise therapy in cancer.
-
Therapies for chronic myeloid leukaemia
Professor Tim Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays and molecular targets that influence the way CML patients are managed world-wide. He has published over 350 papers that have been cited over 65,000 times.
